Seeing Is Believing
Currently out of the existing stock ratings of Tyler Van Buren, 196 are a BUY (83.76%), 35 are a HOLD (14.96%), 3 are a SELL (1.28%).
Analyst Tyler Van Buren, currently employed at TD COWEN, carries an average stock price target met ratio of 38.93% that have a potential upside of 22.42% achieved within 144 days.
Tyler Van Buren’s has documented 425 price targets and ratings displayed on 49 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BHVN, Biohaven Pharmaceutical Holding Co Ltd at 13-Nov-2024.
Analyst best performing recommendations are on BLUE (BLUEBIRD BIO).
The best stock recommendation documented was for BLUE (BLUEBIRD BIO) at 2/24/2021. The price target of $388.6 was fulfilled within 2 days with a profit of $53.02 (15.8%) receiving and performance score of 79.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$4
$1.88 (88.68%)
$5
8 days ago
(15-May-2025)
1/5 (20%)
$1.95 (95.12%)
81
Buy
$33
$30.88 (1456.60%)
$33
8 days ago
(15-May-2025)
3/7 (42.86%)
$30.95 (1509.76%)
884
Buy
$30
$27.88 (1315.09%)
$30
8 days ago
(15-May-2025)
0/6 (0%)
$27.95 (1363.41%)
Buy
$16
$13.88 (654.72%)
$20
6 months 1 days ago
(22-Nov-2024)
1/3 (33.33%)
$9.96 (164.90%)
292
Buy
$6
$4.05 (207.69%)
$4
1 years 8 months 19 days ago
(05-Sep-2023)
4/7 (57.14%)
$4.22 (237.08%)
196
What Year was the first public recommendation made by Tyler Van Buren?